C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/26 (2006.01) A61K 38/38 (2006.01) A61P 3/10 (2006.01) C07K 14/605 (2006.01) C07K 14/765 (2006.01) C07K 19/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2434237
The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
La présente invention concerne des composés GLP-1 fusionnés à des protéines qui ont un effet de prolongation de la demi-vie in vivo des peptides. On peut utiliser ces protéines hybrides pour traiter le diabète non insulino-dépendant, ainsi qu'une diversité d'autres troubles.
Glaesner Wolfgang
Micanovic Radmilla
Tschang Sheng-Hung Rainbow
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Glp-1 fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glp-1 fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glp-1 fusion proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1843820